drugset / Trial / NCT02133989

Clopidogrel Resistance and Embolism in Carotid Artery Stenting

NCT02133989

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of the ticlopidine + ginko biloba compared to clopidogrel in clopidogrel resistant patients undergoing carotid artery stent placement. The investigators hypothesized that ticlopidine + ginko biloba is superior than clopidogrel in terms of post-stent ischemic lesions in these patients without serious complications.

Timeline

Start
2014-06
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 97.875 mg
Subject Ginko Biloba Unknown 80 mg
Subject ticlopidine Small molecule 250 mg

Indications